Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration : Studies in Japan and the United States

© 2019 Kunimoto, Ohji, Maturi, et al.

Détails bibliographiques
Publié dans:Ophthalmic surgery, lasers & imaging retina. - 2013. - 50(2019), 2 vom: 01. Feb., Seite e10-e22
Auteur principal: Kunimoto, Derek (Auteur)
Autres auteurs: Ohji, Masahito, Maturi, Raj K, Sekiryu, Tetsuju, Wang, Ying, Pan, Grace, Li, Xiao-Yan, Schneider, Susan, BAMBOO and CYPRESS Study Groups
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Ophthalmic surgery, lasers & imaging retina
Sujets:Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Angiogenesis Inhibitors Recombinant Fusion Proteins Vascular Endothelial Growth Factor A abicipar pegol M55Q728KNA Ranibizumab ZL1R02VT79